In 2014, Mississippi passed  HB 1231, which included a section known as “Harper Grace’s Law” which creates an affirmative defense for the possession and use of cannabis oil containing high concentrations of CBD (one of the compounds founds in cannabis) in very limited circumstances. Legal protection is only available to patients (and their parent, guardian or custodian) diagnosed with a debilitating epileptic condition or related illness, and only if the CBD oil was either obtained from or tested by the National Center for Natural Products Research at the University of Mississippi and dispensed by the Department of Pharmacy Services at the University of Mississippi Medical Center.

In 2017, the legislature passed SB 2610, to clarify the use of cannabidiol in research for the treatment of seizures and other medical conditions.

Law

HB 1231 (2014) - creates an affirmative defense for the possession and use of cannabis oil containing high concentrations of CBD

SB 2610 (2017) - clarifies the use of cannabidiol in research for the treatment of seizures and other medical conditions.